ISSN: 1369-0663

Journal Home

Journal Guideline

EBR - European Biopharmaceutical Review Q4 Unclaimed

Samedan Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

EBR - European Biopharmaceutical Review is a journal indexed in SJR in Pharmaceutical Science with an H index of 6. It has an SJR impact factor of 0,102 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,102.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,102

SJR Impact factor

6

H Index

0

Total Docs (Last Year)

21

Total Docs (3 years)

0

Total Refs

1

Total Cites (3 years)

19

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Iranian Journal of Pharmaceutical Sciences Q4
Thai Journal of Pharmaceutical Sciences Q4
BioPharm International Q4
Bulletin of Pharmaceutical Sciences Q4
U.S. Pharmacist Q4

Compare this journals

EBR - European Biopharmaceutical Review Q4 Unclaimed

- €

NPD

- €

Metrics

0,102

6

0

21

0

1

19

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of EBR - European Biopharmaceutical Review?